A health worker holds a vial with doses of the Oxford-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (Covid-19), in Paramaribo, Suriname on February 23, 2021 — Reuters/Files